SCHEMBL7716650

SCHEMBL7716650

CN1CCN(c2nc(N)ncc2CCc2ccc(Cl)cc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 13/20 0.53
HTR6 P50406 2/20 0.49
HRH3 Q9Y5N1 2/20 0.43
KCNH2 Q12809 1/20 0.43
OPRL1 P41146 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8139191 0.92 HRH4 (0.45) HRH4HTR6HRH3OPRL1
SCHEMBL7712449 0.89 HTR6 (0.56) HRH4HTR6HRH3KCNH2
SCHEMBL7712408 0.86 ROCK2 (0.43) HRH4
SCHEMBL7714119 0.81 HRH4 (0.53) HRH4HTR6
SCHEMBL7712432 0.80 GAA (0.45)
SCHEMBL7714283 0.80 HRH4 (0.57) HRH4HTR6
SCHEMBL8124120 0.78 HTR6 (0.45) HRH4HTR6HRH3
SCHEMBL7714282 0.78 HRH4 (0.56) HRH4HTR6HRH3KCNH2
SCHEMBL7708437 0.77 KDM4E (0.44) HRH4HTR6
SCHEMBL7713555 0.77 HRH4 (0.52) HRH4HTR6HRH3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed